Patent and Trademark Office Grants Reissued Patent Replacing OSI Pharma's (OSIP) Tarceva Composition of Matter Patent
Tweet Send to a Friend
OSI Pharmaceuticals, Inc. (NASDAQ: OSIP) today announced that the U.S. Patent & Trademark Office has granted reissue patent RE41,065, replacing ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
